Neoalbaconol inhibits angiogenesis and tumor growth by suppressing EGFR‐mediated VEGF production

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Molecular Carcinogenesis

• Publication date

  2017-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/mc.22602PMID 27996164
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma

  2015cited by this paper
• Broad targeting of angiogenesis for cancer prevention and therapy

  2015cited by this paper
• VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2

  2014cited by this paper
• Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions

  2014cited by this paper
• Breast cancer statistics, 2013

  2014cited by this paper
• Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer.

  2013cited by this paper
• Breast Cancer Statistics

  2013cited by this paper
• Neoalbaconol induces energy depletion and multiple cell death in cancer cells by targeting PDK1-PI3-K/Akt signaling pathway

  2013cited by this paper
• Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial.

  2013cited by this paper
• Autocrine VEGF–VEGFR2–Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth

  2012cited by this paper
• Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• EGFR- and VEGF(R)-Targeted Small Molecules Show Synergistic Activity in Colorectal Cancer Models Refractory to Combinations of Monoclonal Antibodies

  2011cited by this paper
• Forty-Year Journey of Angiogenesis Translational Research

  2011cited by this paper
• Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway.

  2010cited by this paper
• Tissue Microarray

  2010cited by this paper
• mTOR Inhibitor RAD 001 ( Everolimus ) Has Antiangiogenic / Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor

  2009cited by this paper
• mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor

  2009cited by this paper
• A review of the current research on the role of bFGF and VEGF in angiogenesis.

  2009cited by this paper
• The angiogenic switch in carcinogenesis.

  2009cited by this paper
• Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.

  2009cited by this paper
• Evolution of bevacizumab-based therapy in the management of breast cancer.

  2008cited by this paper
• Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways

  2008cited by this paper
• EGFR antagonists in cancer treatment.

  2008cited by this paper
• Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling.

  2008cited by this paper
• Vascular Endothelial Growth Factor Mediates Intracrine Survival in Human Breast Carcinoma Cells through Internally Expressed VEGFR1/FLT1

  2007cited by this paper
• EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms.

  2006cited by this paper
• Vascular endothelial growth factor, FLT‐1, and FLK‐1 analysis in a pancreatic cancer tissue microarray

  2006cited by this paper
• Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus.

  2006cited by this paper
• Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis

  2004cited by this paper
• The sponge/Matrigel angiogenesis assay

  2004cited by this paper
• Angiogenesis: Tumorigenesis and the angiogenic switch

  2003cited by this paper
• The biology of VEGF and its receptors

  2003cited by this paper
• ErbB-2 activates Stat3 alpha in a Src- and JAK2-dependent manner.

  2002cited by this paper
• Blockade of the epidermal growth factor receptor signaling inhibits angiogenesis leading to regression of human renal cell carcinoma growing orthotopically in nude mice.

  2002influential reference
• ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase.

  2002influential reference
• ErbB-2 Activates Stat3α in a Src- and JAK2-dependent Manner*

  2002cited by this paper
• Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias

  2001cited by this paper
• Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.

  2000cited by this paper
• ErbB Receptor-induced Activation of Stat Transcription Factors Is Mediated by Src Tyrosine Kinases*

  1999influential reference
• Identification of EGF as an angiogenic factor present in conditioned medium from human salivary gland adenocarcinoma cell clones with varying degrees of metastatic potential.

  1994cited by this paper
• Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology.

  1993influential reference
• Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor.

  1986cited by this paper

• Hypoxia-driven angiogenesis and metabolic reprogramming in vascular tumors

  2025cites this paper
• The Mushroom Albatrellus confluens: A Minireview on Phytochemistry, Biosynthesis, Synthesis and Pharmacological Activities.

  2024cites this paper
• Elucidating the molecular mechanism of angiogenic activity of sulfate glycosaminoglycan derived from fish swim bladder in human umbilical vein endothelial cells

  2024cites this paper
• Effectiveness of adjuvant traditional Chinese medicine on macrovascular invasion in patients with hepatocellular carcinoma: a real-world propensity score-matched study

  2024cites this paper
• Research progress in tumor angiogenesis and drug resistance in breast cancer

  2024cites this paper
• Exosomes Derived From Mesenchymal Stem Cells Pretreated With Ischemic Rat Heart Extracts Promote Angiogenesis via the Delivery of DMBT1

  2022cites this paper
• Forkhead Box q1 promotes invasion and metastasis in colorectal cancer by activating the epidermal growth factor receptor pathway

  2022cites this paper
• The Efficacy and Safety of Anlotinib Alone and in Combination with Other Drugs in Advanced Lung Cancer: A Retrospective Cohort Study

  2022cites this paper
• Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways

  2022cites this paper
• Facile and divergent optimization of chromazonarol enabled the identification of simplified drimane meroterpenoids as novel pharmaceutical leads.

  2021cites this paper
• A Pan-cancer Analysis Reveals the Abnormal Expression and Drug Sensitivity of CSF1.

  2021cites this paper
• Hemangioma Endothelial Cells and Hemangioma Stem Cells in Infantile Hemangioma

  2021cites this paper
• The role of anlotinib-mediated EGFR blockade in a positive feedback loop of CXCL11-EGF-EGFR signalling in anaplastic thyroid cancer angiogenesis

  2021cites this paper
• VEGI downregulation is correlated with nodal metastasis and poor prognosis in lung adenocarcinoma

  2020influential citation
• Highlight article: Neural stem cell-derived exosomes facilitate spinal cord functional recovery after injury by promoting angiogenesis

  2020cites this paper
• TGFαL3-SEB fusion protein as an anticancer against ovarian cancer.

  2020cites this paper
• The Role of Necroptosis in ROS-Mediated Cancer Therapies and Its Promising Applications

  2020cites this paper
• Novel single-domain antibodies against the EGFR domain III epitope exhibit the anti-tumor effect

  2020cites this paper
• miR-503 Inhibits Proliferation, Migration, And Angiogenesis Of Glioma By Acting On VEGFA Through Targeting LRIG2

  2019cites this paper
• Cell Biology International

  2019cites this paper
• Phytochemicals Targeting VEGF and VEGF-Related Multifactors as Anticancer Therapy

  2019cites this paper
• Repression of Hexokinases II-Mediated Glycolysis Contributes to Piperlongumine-Induced Tumor Suppression in Non-Small Cell Lung Cancer Cells

  2019cites this paper
• Effect of autophagy inhibitor 3-methyladenine combined with TP chemotherapy on nasopharyngeal carcinoma and EGFR and VEGF levels in tissues

  2019cites this paper
• Xanthohumol inhibits colorectal cancer cells via downregulation of Hexokinases II-mediated glycolysis

  2019cites this paper
• Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin

  2019cites this paper
• ERα-mediated alterations in circ_0023642 and miR-490-5p signaling suppress bladder cancer invasion

  2019cites this paper
• Antiangiogenic effect of crocin on breast cancer cell MDA-MB-231.

  2019influential citation
• CMAR_A_222681 10599..10608

  2019cites this paper
• IDH2 is a novel diagnostic and prognostic serum biomarker for non‐small‐cell lung cancer

  2018cites this paper
• Deguelin attenuates non-small cell lung cancer cell metastasis through inhibiting the CtsZ/FAK signaling pathway.

  2018cites this paper
• Butein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activity

  2018cites this paper
• Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancer

  2018cites this paper
• By blocking hexokinase-2 phosphorylation, limonin suppresses tumor glycolysis and induces cell apoptosis in hepatocellular carcinoma

  2018cites this paper
• Targeting VEGF/VEGFRs Pathway in the Antiangiogenic Treatment of Human Cancers by Traditional Chinese Medicine

  2018cites this paper
• Effects of Aptamer to U87-EGFRvIII Cells on the Proliferation, Radiosensitivity, and Radiotherapy of Glioblastoma Cells

  2018cites this paper
• Exosomal DMBT1 from human urine-derived stem cells facilitates diabetic wound repair by promoting angiogenesis

  2018cites this paper
• Deguelin, an Aurora B Kinase Inhibitor, Exhibits Potent Anti-Tumor Effect in Human Esophageal Squamous Cell Carcinoma

  2017cites this paper
• Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway.

  2017cites this paper
• The correlation of the quantitative ultrasonography parameters with the liver cancer cell proliferation activity and intralesional angiogenesis

  2017influential citation
• Forward-reverse mutation cycles between stages of cancer development

  2017cites this paper
• Oxymatrine inhibits non–small cell lung cancer via suppression of EGFR signaling pathway

  2017cites this paper
• Circular RNA profile of infantile hemangioma by microarray analysis

  2017cites this paper
• Downregulation of LRIG2 expression inhibits angiogenesis of glioma via EGFR/VEGF-A pathway

  2017cites this paper
• World Journal of Gastrointestinal Oncology

  year unknowncites this paper